ACSL1 and thyroid cancer: The high expression of acyl-CoA synthetase long-chain family member 1 (ACSL1) inhibits the progression of thyroid cancer cells and activates fatty acid metabolism reprogramming during cancer cell metastasis, thereby achieving an antagonizing effect of ferroptosis on tumour cells [79–81].